VENUSREM Financial Statements

Venus Remedies Key Financial Ratios

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 61.50 (8.90) (6.90) (4.40)
Op profit growth 31.70 3.41 (22) (38)
EBIT growth 170 78.80 (38) (69)
Net profit growth (718) (67) 79.70 (1,105)
Profitability ratios (%)        
OPM 9.81 12 10.60 12.70
EBIT margin 6.96 4.16 2.12 3.18
Net profit margin 11.30 (2.90) (8.20) (4.30)
RoCE 7.51 2.27 1.13 1.69
RoNW 4.27 (0.70) (2) (1)
RoA 3.04 (0.40) (1.10) (0.60)
Per share ratios ()        
EPS 50 (8.10) -- --
Dividend per share -- -- -- --
Cash EPS 21.50 (34) (52) (46)
Book value per share 324 262 293 315
Valuation ratios        
P/E 5.49 (2.80) -- --
P/CEPS 12.80 (0.70) (1.30) (2.10)
P/B 0.85 0.09 0.22 0.31
EV/EBIDTA 4.92 5.34 9.20 8.10
Payout (%)        
Dividend payout -- -- -- --
Tax payout 52.60 (253) 11.50 (21)
Liquidity ratios        
Debtor days 20.90 41.90 46.30 49.70
Inventory days 86.90 150 137 130
Creditor days (40) (41) (33) (29)
Leverage ratios        
Interest coverage (2.90) (1.10) (0.20) (0.40)
Net debt / equity 0.06 0.68 0.84 0.79
Net debt / op. profit 0.42 5.35 7.67 6.07
Cost breakup ()        
Material costs (62) (51) (55) (57)
Employee costs (8.40) (14) (11) (8.60)
Other costs (20) (23) (24) (22)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 548 339 372 400
yoy growth (%) 61.50 (8.90) (6.90) (4.40)
Raw materials (341) (174) (205) (227)
As % of sales 62.20 51.40 55.10 56.80
Employee costs (46) (46) (39) (34)
As % of sales 8.40 13.60 10.60 8.57
Other costs (108) (78) (89) (88)
As % of sales 19.60 23 23.80 22
Operating profit 53.80 40.80 39.50 50.70
OPM 9.81 12 10.60 12.70
Depreciation (35) (32) (34) (40)
Interest expense (13) (13) (35) (34)
Other income 19.60 5.31 2.25 2.27
Profit before tax 25.10 0.78 (28) (22)
Taxes 13.20 (2) (3.20) 4.56
Tax rate 52.60 (253) 11.50 (21)
Minorities and other -- -- -- --
Adj. profit 38.30 (1.20) (31) (17)
Exceptional items 23.40 (8.80) -- --
Net profit 61.80 (10) (31) (17)
yoy growth (%) (718) (67) 79.70 (1,105)
NPM 11.30 (2.90) (8.20) (4.30)
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 25.10 0.78 (28) (22)
Depreciation (35) (32) (34) (40)
Tax paid 13.20 (2) (3.20) 4.56
Working capital 26 80.30 22.90 2.60
Other operating items -- -- -- --
Operating cashflow 29 47.10 (42) (55)
Capital expenditure 273 193 189 97.70
Free cash flow 302 240 147 43
Equity raised 557 621 751 844
Investments -- -- -- --
Debt financing/disposal (91) 123 179 73.40
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 768 984 1,077 961
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 26.10 12.30 12.30 12.30
Preference capital -- -- -- --
Reserves 374 311 320 350
Net worth 400 323 333 362
Minority interest
Debt 51.30 220 298 307
Deferred tax liabilities (net) 3.63 16.90 14.90 16
Total liabilities 455 561 645 685
Fixed assets 287 314 429 454
Intangible assets
Investments -- -- -- --
Deferred tax asset (net) -- -- -- --
Net working capital 139 245 213 227
Inventories 120 141 143 138
Inventory Days 79.90 152 -- 135
Sundry debtors 32 30.70 38 47.30
Debtor days 21.30 33 -- 46.30
Other current assets 88.10 156 120 107
Sundry creditors (72) (37) (36) (30)
Creditor days 47.90 39.70 -- 29.20
Other current liabilities (29) (46) (51) (36)
Cash 29 2.13 2.81 3.98
Total assets 455 561 645 685
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Dec-2021 Sep-2021 Jun-2021 Mar-2021 Dec-2020
Gross Sales 124 203 130 111 122
Excise Duty -- -- -- -- --
Net Sales 124 203 130 111 122
Other Operating Income -- -- -- -- --
Other Income 1.22 2.89 1.95 24.10 6.29
Total Income 126 205 132 135 128
Total Expenditure ** 112 175 113 107 104
PBIDT 13.70 30.20 18.80 28.50 24.40
Interest 0.31 0.03 0.14 0.96 1.81
PBDT 13.30 30.20 18.60 27.60 22.60
Depreciation 8.64 8.71 8.62 9.38 8.70
Minority Interest Before NP -- -- -- -- --
Tax (1) (1.70) (1.70) (17) 2.21
Deferred Tax -- -- -- -- --
Reported Profit After Tax 5.65 23.20 11.70 35.10 11.70
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 5.65 23.20 11.70 35.10 11.70
Extra-ordinary Items -- -- -- 20.60 3.75
Adjusted Profit After Extra-ordinary item 5.65 23.20 11.70 14.60 7.91
EPS (Unit Curr.) 4.22 17.30 8.86 28.50 9.44
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 13.40 13.40 13.40 12.30 12.30
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 11 14.90 14.50 25.60 20
PBDTM(%) 10.70 14.90 14.40 24.80 18.50
PATM(%) 4.54 11.40 9.01 31.50 9.56
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity